| License: Creative Commons Attribution 4.0 PDF - Published Version (703kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-589126
- DOI to cite this document:
- 10.5283/epub.58912
Abstract
Background: Tumor necrosis factor alpha (TNF) is able to kill cancer cells via receptor-mediated cell death requiring adenosine triphosphate (ATP). Clinical usage of TNF so far is largely limited by its profound hepatotoxicity. Recently, it was found in the murine system that specific protection of hepatocytes against TNF's detrimental effects can be achieved by fructose-mediated ATP depletion ...

Owner only: item control page

Download Statistics